Flebaven 1000 film-coated tablets 1000 mg 30 pcs.

The active ingredient is diosmin (one tablet contains 1000 mg of micronized diosmin).

Excipients: polyvinyl alcohol, croscarmellose sodium, magnesium stearate.

Hypersensitivity to the active substance or any excipient.

For oral use.

Intended for adults. Tablets should be taken with meals.

Chronic venolymphatic insufficiency

The recommended dose is one tablet per day in the morning. The duration of treatment is at least 4-5 weeks.

Hemorrhoid disease

Treatment of acute hemorrhoid episodes: 3 tablets per day for 4 days, then two tablets per day for the next 3 days. The daily dose should be divided into 2-3 doses. Maintenance therapy – one tablet per day.

The duration of treatment is determined by the doctor depending on the indications for use and the course of the disease.

Pregnant women

Pregnant women should use Flebaven 1000 with caution. Consult a doctor before use.

Studies have not revealed any teratogenic effects of the drug; no side effects have been reported.

Due to the lack of data on its penetration into breast milk, use during lactation should be avoided.

Reproductive toxicity studies in animals showed no effect on fertility.

Drivers

No studies on the effect of diosmin on the ability to drive or use machines have been conducted. However, based on the overall safety profile, diosmin has no or negligible influence on this ability.

No cases of overdose have been reported.

During clinical studies, side effects of moderate intensity were observed with the use of diosmin, mainly from the gastrointestinal tract (diarrhea, dyspepsia, nausea, vomiting).

Store in the original packaging to protect from moisture at a temperature not exceeding 25 °C, out of the reach of children.

Shelf life – 3 years.